Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable
Background No tools to predict the probability of extrahepatic disease progression (ePD) of initially unresectable, liver-limited metastatic colorectal cancer (mCRC) are currently available. To estimate the likelihood to develop ePD and to identify clinical and molecular factors that could predict e...
Main Authors: | Vincenzo Mazzaferro, Chiara Cremolini, Filippo Pagani, Daniele Rossini, Beatrice Borelli, Elena Ongaro, Filippo de Braud, Alfredo Falcone, Francesca Corti, Luca Morelli, Lucio Urbani, Gianluca Masi, Carlo Sposito, Beatrice Filippi, Gemma Zucchelli, Roberto Moretto, Alessandra Boccaccino, Leonardo Solaini, Alessandro Cucchetti |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-04-01
|
Series: | ESMO Open |
Online Access: | https://esmoopen.bmj.com/content/4/2/e000496.full |
Similar Items
-
Advances in Application of PDT Combined with Multiple Therapies on Unresectable Extrahepatic Cholangiocarcinoma
by: HE Puyi, et al.
Published: (2021-09-01) -
AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer
by: Carlotta Antoniotti, et al.
Published: (2020-07-01) -
Deem Estádios ao Brasil
by: Revista de Educação Física
Published: (2020-08-01) -
Deem Estádios ao Brasil
by: Revista de Educação Física
Published: (1942-07-01) -
Deem Estádios ao Brasil
by: Revista de Educação Física
Published: (2020-08-01)